I think we all agree that the ART-123 results in the published paper were not great. But the results from the phase-2b trial just starting could turn out better, so it’s premature, IMO, to write off ART-123 just yet. Regards, Dew
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”